THE HEALTH OF BABIES BORN TO WOMEN WITH PREGNANCY-ASSOCIATED BREAST CANCER
- Authors: VOLOCHAEVA M.V1, SHMAKOV R.G1, ZUBKOV V.V1
-
Affiliations:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 7 (2014)
- Pages: 33-37
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247215
- ID: 247215
Cite item
Abstract
Full Text
About the authors
M. V VOLOCHAEVA
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: volochaeva.m@yandex.ru
3rd year postgraduate 117997, Russia, Moscow, Ac. Oparin str. 4
R. G SHMAKOV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: mdshmakov@mail.ru
doctor of medicine, the head of the obstetric department 117997, Russia, Moscow, Ac. Oparin str. 4
V. V ZUBKOV
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: v_zubkov@oparina4.ru
doctor of medicine, the head of the neonatology and pediatry department 117997, Russia, Moscow, Ac. Oparin str. 4
References
- Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. GLOBOCAN 2008. Cancer incidence and mortality worldwide: IARC Cancer Base No. 10 Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr, accessed on 27/06/2013.
- Чиссов В.И., Старинский В.В., Петрова Г.В., ред. Злокачественные заболевания в России в 2011 году (заболеваемость и смертность). М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2013. 289 с
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Состояние онкологической помощи населению России в 2012 году. М.: ФГБУ «МНИОИ им. П.А. Герцена» Минздрава России; 2013. 232 с
- Centers for Disease Control and Prevention. Available at: www.cdc.gov/cancer/ dcpc/data/women.htm. Retrieved June 2012.
- Cardonick Е., Gilmandyar D., Somer R.A. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet. Gynecol. 2012; 120: 1267-72.
- Loibl S., Han S.N., Amant F. Being pregnant and diagnosed with breast cancer. Breast Care (Basel). 2012; 7(3): 204-9.
- Van Calsteren K., Heyns L., De Smet F., Van Eycken L., Gziri M.M., Van Gemert W. et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J. Clin. Oncol. 2010; 28(4): 683-9.
- Amant F., Han S.N., Gziri M.M., Dekrem J., Van Calsteren K. Chemotherapy during pregnancy. Curr. Opin. Oncol. 2012; 24(5): 580-6.
- Langagergaard V. Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin’s disease: a review. Clin. Epidemiol. 2011; 3: 7-19.
- Ring A.E., Smith I.E., Jones A., Shannon C., Galani E., Ellis P.A. Chemotherapy for breast cancer during pregnancy: An 18-year experience from five London teaching hospitals. J. Clin. Oncol. 2005; 23(18): 4192-7.
- Abdel-Hady el-S., Hemida R.A., Gamal A., El-Zafarany M., Toson E., El-Bayoumi M.A. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch. Gynecol. Obstet. 2012; 286(2): 283-6.
- Achtari C., Hohlfeld P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am. J. Obstet. Gynecol. 2000; 183(2): 511-2.
- Siu B.L., Alonzo M.R., Vargo T.A., Fenrich A.L. Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int. J. Gynecol. Cancer. 2002; 12(4): 399-402.
- Gziri M.M., Hui W., Amant F. Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur. J. Pediatr. 2013; 172: 163-70.
- Amant F., Van Calsteren K., Halaska M.J. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol. 2012; 13(3): 256-64.
- Azim H.A., Del Mastro L., Scarfone G., Peccatori F.A. Treatment of breast cancer during pregnancy: regimen selection, pregnancy monitoring and more. Breast. 2010; 20(1): 1-6.
- Perry M.C., Mckinney N.F. The chemotherapeutic agents. In: Perry M.C., ed. Chemotherapy source book. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008; appendix I: 575-633.
- Garcia L., Valcarcel M., Santiago-Borrero P.J. Chemotherapy during pregnancy and its effects on the fetus--neonatal myelosuppression: two case reports. J. Perinatol. 1999; 19(3): 230-3.
- Baumgärtner A.K., Oberhoffer R., Jacobs V.R., Ostermayer E., Menzel H., Voigt M. et al. Reversible fetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie. 2009; 32(1-2): 40-3.
- Massey Skatulla L., Loibl S., Schauf B., Müller T. Pre-eclampsia following chemotherapy for breast cancer during pregnancy: case report and review of the literature. Arch. Gynecol. Obstet. 2012; 286(1): 89-92.